Alexion to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology
BOSTON--(BUSINESS WIRE)--Sep 25, 2018--Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the Leerink Partners Roundtable Series: Rare Disease & Oncology in New York, NY on Tuesday, October 2, 2018 at 10 a.m., EDT.
An audio webcast of the presentation will be available live. You can access the webcast at: http://ir.alexion.com. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180925006098/en/
CONTACT: Alexion Pharmaceuticals
Susan Altschuller, Ph.D.
Vice President, Investor Relations
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL OTHER HEALTH RESEARCH OTHER SCIENCE SCIENCE
SOURCE: Alexion Pharmaceuticals
Copyright Business Wire 2018.
PUB: 09/25/2018 04:30 PM/DISC: 09/25/2018 04:30 PM